How much is life worth? The $440 billion question
The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S. that needs to be addressed by the oncology community, according to a commentary published online June 29 in the Journal of the National Canc...
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Small Molecule Kinase Inhibitors market. World market for small molecule kinase inhibitor drugs is projected to reach $16.2 billion
by the year 2015. This is primarily driven by the rising interest over the potential of kinase inhibito...
Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Prescription Drugs market. The global prescription drugs market is witnessing a significant deceleration in growth. Key factors slowing down growth in the global prescription drugs market include economic downturn, increasing number of...
Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
HORSHAM, Pa., June 29 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that a federal jury has returned a verdict of $1.67 billion
against Abbott Laboratories in a patent infringement suit.
"We are pleased that the jury has ruled in our favor in the patent litigation case against A...
World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Nanomedicine markets. The global Nanomedicine market continues to register robust growth largely fueled by unique properties of nanoparticles that provide novel and improved advantages, introduction of novel products, healthy rise in f...
Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) ( http://www.BMSN.us ), an emerging research and development biotechnology company focused on the full spectrum of adult stem cells at its commercial cryogenic stem cell bank and processing fa...
Heart Health Month Milestone: Half a Billion Pounds of Bad Fats Eliminated From North American Diet
Omega-9 Canola and Sunflower Oils drive better restaurant menu options
INDIANAPOLIS, Feb. 25 /PRNewswire/ -- This year's Heart Health Month marks a significant milestone in North America with the reduction of nearly a half billion
pounds of trans and saturated fats over the past three years. ...
World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
Driven by the human genome project, and research in the area of AIDS, geriatric diseases, neurosciences, and drug development (antiviral, antibacterial, antifungal, and genetic therapeutics), world market for biotechnology reagents is projected to reach $32.5 billion
by 2012. The shift towards pr...
Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
Advances in biotechnology and life science research coupled with broader range of application areas are expected to drive growth in the cell/tissue culture market. Growth is likely to be fueled by heightened interest in biopharmaceutical therapeutics, human and veterinary vaccine applications, an...
Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts
Rising concerns over food and water safety worldwide continue to increase the need for testing contaminants thereby generating strong demand for agricultural and environmental diagnostics. Market size projections look bright with the 2012 figure expected to touch $2.4 billion. Europe is the large...
World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
Gene Amplification technology is one of the rapidly growing markets in life science field. By the year 2015, global market for Gene Amplification technologies is projected to reach $2.2 billion. Major factors that continue to affect the industry are patent expiry, and competitive advantages assoc...
Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
Driven by the emergence of innovative technologies such as microfluidics, genomics, high throughput screening and proteomics, world market for drug discovery technologies is projected to reach $57.7 billion
by 2012. Despite the heavy costs involved in discovery of new drugs, investments in pharma...
Microplate Instrumentation & Supplies Market to Exceed $5.0 Billion by 2015, According to New Report by Global Industry Analysts, Inc
Driven by the burgeoning demand from drug discovery research and high throughput screening applications, global market for microplate instrumentation & supplies is projected to amount to $5.0 billion
by 2015. A key driving force is the increasing involvement of pharmaceutical and biotechnolog...
Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
Global Genetic testing market is projected to grow at a healthy pace to exceed $6.6 billion
by 2015. The market is primarily driven by growing incidence of genetic diseases and growing consumer awareness and rising interest towards genetic testing.
San Jose, CA (PRWEB) ...
Laboratory Pumping Systems to Reach $3.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
Phenomenal growth in large-scale applications such as combinatorial chemistry is expected to fuel demand for standard as well as highly specialized laboratory equipment including laboratory pumps. Backed by favorable end-use trends, the market is projected to reach US$3.1 billion
LF Elimination Program Treats Over Half Billion People and Protects Millions More From Debilitating Disease
- Study demonstrates 'Best buy in public health'
LONDON, Oct. 7 /PRNewswire-FirstCall/ -- A study published today
confirms that in the ten years since its initiation, the international
effort to eliminate lymphatic filariasis (LF) has made unprecedented
strides towards ridding the ...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
Creates a Global Leader in Oncology Biopharmaceuticals
Boosts Oncology Pipeline With Up to Three Promising Targeted Therapies in Phase III in 2009
INDIANAPOLIS and NEW YORK, Oct. 6 /PRNewswire-FirstCall/ -- Eli Lilly
and Company (NYSE: LLY ) and ImClone Sys...
Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
PRINCETON, N.J., Oct. 3 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE:
CVD), one of the world's largest and most comprehensive drug development
services companies, today announced that it has closed its transaction with
Eli Lilly and Company to provide a broad-range of drug development services...
Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
BOSTON, Sept. 30 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink
Sheets: SNDY) is pleased to announce that the Company intends to expand
their current industry to include and capitalize on the $30 billion
minimally invasive instrumentation market by implementing a business
strategy. The ...
US Neuropathic Pain Market Value Doubles to $5 Billion by 2018
New Indications and Products Offset Patent Expirations
SAN FRANCISCO, Sept. 11 /PRNewswire/ -- The U.S. market for drug
treatment of major neuropathic pain (NP) conditions is currently valued at
$2.6 billion, according to US Neuropathic Pain, a report released today by
WWMR, Inc. Grow...
Body Shaping Fuels Growth of $5.2 Billion Global Medical Aesthetic Market
ALISO VIEJO, Calif., Aug. 4 /PRNewswire/ -- Over the next five years,
new body shaping and skin tightening technologies will drive double-digit
growth in the global aesthetic industry, according to the just-released
Global Aesthetic Market V research report from Medical Insight, Inc.
90 billion tons of microbial organisms live in the deep biosphere
Biogeoscientists show evidence of 90 billion
tons of microbial organismsexpressed in terms of carbon massliving in the deep biosphere, in a research article published online by Nature , July 20, 2008. This tonnage corresponds to about one-tenth of the amount of carbon stored globally in tropical ...
Spectrum Blue Steel's fresh foreign investment at 18 Billion and the Biosphere process spark attention on a global scale
Spectrum Blue steel's announcement to clean the dump sites and get rid of the garbage has sparked allot of attention. One day after the 18 billion
dollar announcement to build 1500 biosphere units in the Philippines environmental Secretary Jose Atienza warned local chief executives they risk...
CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years
Creation of Clear Regulatory Pathway Would Also Lower Total
Expenditures for Biologics by $25 Billion
Over Ten Years
WASHINGTON, June 25 /PRNewswire-USNewswire/ -- The Congressional Budget
Office (CBO) today released a cost analysis finding that the creation of an
abbreviated pathway for foll...
Bristol-Myers Squibb Issues $1.6 Billion of Senior Notes
NEW YORK, April 29 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb
Company (NYSE: BMY ) announced today that it has agreed to sell $1.6 billion
of senior unsecured notes: $600 million in aggregate principal amount of
5.450% notes due May 1, 2018 and $1 billion
in aggregate principal amount
R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007
WASHINGTON, March 24 /PRNewswire-USNewswire/ -- America's
pharmaceutical and biotechnology research companies invested a record $58.8
billion last year in the research and development of new life-changing
medicines and vaccines -- an increase of nearly $3 billion
according to analys...
Medco Issues $1.5 Billion of Senior Notes
FRANKLIN LAKES, N.J., March 13 /PRNewswire-FirstCall/ -- Medco Health
Solutions, Inc. (NYSE: MHS ) announced today that it has agreed to sell $300
million aggregate principal amount of 6-1/8 percent senior notes due March
15, 2013 and $1.2 billion
aggregate principal amount of 7-1/8 percent
Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.
Q4 2007 SALES INCREASE 14.6%. Q4 2007 DILUTED EPS UP 20.8% TO $.64. 2008 DILUTED EPS GUIDANCE UP 7.7% - 12.0% TO $2.52 - $2.62 PER SHARE.
ST. LOUIS, Feb. 12 /PRNewswire-FirstCall/ --
HIGHLIGHTS: 2007 Results (all percentage comparisons are to comparable periods in
-- Q4 2007...
Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
RICHMOND, Va., Feb. 11 /PRNewswire-FirstCall/ -- A report released
today, commissioned by Insmed Inc. (Nasdaq: INSM ), identifies potential
cost savings of approximately $378 billion
over the next 20 years from
making follow on biologics (FOBs) available in the U.S.
The econometric study by...
Foamix Signs Term Sheet to Acquire License to Organo-Boron Antifungal Molecules - Will Target the $11 Billion Dollars Fungal Infection Market
NESS ZIONA, and TEL AVIV, Israel, January 31 /PRNewswire/ -- Foamix
Ltd. a leading worldwide developer of topical foams for dermatology and
gynecology and Ramot at Tel Aviv University Ltd., have reached an agreement
on the commercial terms of a worldwide exclusive license for Organo-Boron
Surgical and Trauma Wound Care Market to Tie Up $7 Billion in Sales by 2011
NEW YORK, Dec. 5 /PRNewswire/ -- Driven by an aging population and
continued advances in biotechnology, the worldwide surgical and trauma
wound treatment market is expected to post a compound annual growth rate of
5.5% and grow to $7 billion
by 2011, according to Wound Care Markets,
Entry of Biogenerics and Decreasing Use of Amgen's Epogen and Johnson & Johnson's Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
Upheaval is Forecasted for the Markets of Five Chemotherapy Side Effect Indications, According to a New Report from Decision Resources
WALTHAM, Mass., Oct. 29 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and
Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
MADISON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE )
announced that, at a meeting today, its Board of Directors approved an
increase to the Company's previously authorized share repurchase program
that authorizes the Company to buy back up to $5 billion
of the Company's
Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
NEW YORK, Sept. 6 /PRNewswire/ -- Globally, approximately 418 billion
people are currently infected with hepatitis, and the unrecognized
importance, danger, and costs of hepatitis in the 21st century cannot be
understated or underestimated, according to Global Hepatitis Strategies, a
Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
NATICK, Mass., Aug. 23 /PRNewswire-FirstCall/ -- Boston Scientific
Corporation (NYSE: BSX ) today announced that it has successfully amended
its $2 billion
revolving line of credit and $5 billion
term loan agreement,
providing the Company additional financial flexibility as it implements
Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 19
/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) the global
specialty biopharmaceutical company announces results for the year to
December 31, 2008 - a year which has seen significant growth in Shire's new
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
- Acquisition Accelerates Takeda's Vision of Becoming a Global Leader in Oncology -
OSAKA, Japan, and CAMBRIDGE, Mass., April 10 /PRNewswire-FirstCall/ --
Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Millennium
Pharmaceuticals, Inc. (Nasdaq: ML...
Baxter's Board of Directors Approves New Share Repurchase Authorization of $2 Billion
DEERFIELD, Ill., March 18 /PRNewswire-FirstCall/ -- Baxter
International Inc. (NYSE: BAX ) announced today that its Board of Directors
has approved the repurchase of an additional $2 billion
of the company's
common stock to be executed upon completion of the company's existing share
Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
-- Strategic Acquisition Creates Premier Provider of Diabetes Care Services With 3.8 Million Patients Under Treatment
-- Diabetes Patients Represent 5 Percent of Population; 15 Percent of Drug Spending
-- Transaction Expected to be Slightly Accretive ...
Alzheimer's drug market to hit $5.5 billion by 2009, study says
Toronto-based Millennium Research Group predicts the Alzheimer's disease drug market in the United States, Europe and Japan will grow by 15 percent annually for the next five years.
Pharmaceutical manufacturers profiled in Millennium's study, entitled "Global Markets for Alzheimer's Disease Me...